Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors is a research paper published in European Journal of Cancer (2022). On theSindex it has a DataRank of 0. It has been cited 45 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Fondation ISREC
Grant: P01-CA240239
Fondation ISREC
Grant: NVKP_16-1\u20132016-0017
Fondation ISREC
Grant: R01-CA218579
Fondation ISREC
Grant: R01-CA206890
National Heart, Lung, and Blood Institute
Grant: K24HL150238
National Heart, Lung, and Blood Institute
Grant: R01HL137562
National Heart, Lung, and Blood Institute
Grant: R01HL130539
National Institutes of Health
Grant: R35-CA197743
National Institutes of Health
Grant: U01-CA224348
National Institutes of Health
Grant: R01-CA259253
National Institutes of Health
Grant: R01-CA208205 R01-NS118929
NCI NIH HHS
Grant: R01 CA206890
NCI NIH HHS
Grant: R01 CA208205
NCI NIH HHS
Grant: R01 CA269672
NINDS NIH HHS
Grant: R01 NS118929
NCI NIH HHS
Grant: R35 CA197743
NCI NIH HHS
Grant: U01 CA224348
NCI NIH HHS
Grant: P01 CA240239
NCI NIH HHS
Grant: R01 CA218579
NCI NIH HHS
Grant: R01 CA259253
Innovációs és Technológiai Minisztérium
Semmelweis Egyetem
National Foundation for Cancer Research
Advanced Medical Research Foundation
FWCI
6.00
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals